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Two challenging problems in the clinical study of cancer are the
characterization of cancer subtypes and the classification of individ-
ual patients according to those subtypes. Statistical approaches ad-
dressing these problems are hampered by population heterogeneity
and challenges inherent in data integration across high-dimensional,
diverse covariates. We have developed a survival-supervised latent
Dirichlet allocation (survLDA) modeling framework to address these
concerns. LDA models have proven extremely effective at identify-
ing themes common across large collections of text, but applications
to genomics have been limited. Our framework extends LDA to the
genome by considering each patient as a “document” with “text” con-
structed from clinical and high-dimensional genomic measurements.
We then further extend the framework to allow for supervision by
a time-to-event response. The model enables the efficient identifi-
cation of collections of clinical and genomic features that co-occur
within patient subgroups, and then characterizes each patient by
those features. An application of survLDA to The Cancer Genome At-
las (TCGA) ovarian project identifies informative patient subgroups
that are characterized by different propensities for exhibiting abnor-
mal mRNA expression and methylations, corresponding to differen-
tial rates of survival from primary therapy.
1. Introduction. Technological advances continue to increase both the ease and accuracy with
which measurements of the genome and phenome can be obtained and, consequently, genomic-based
studies of disease often involve highly diverse types of data collected on large groups of patients. The
primary goals of such studies involve identifying genomic features useful for characterizing patient
subgroups as well as predicting patient-specific disease course and/or likelihood of response to treat-
ment. Doing so requires statistical methods that handle complex interactions, accommodate population
heterogeneity, and allow for data integration across multiple sources.
A number of statistical methods are available for survival-related feature identification and predic-
tion (for a review, see Witten and Tibshirani (2009); Li and Li (2004); Wei and Li (2007)). Most
often, classical models for a survival response are coupled with some dimension-reduction method
for individual (Li and Luan, 2003; Ghosh and Yuan, 2010; Pang, Datta and Zhao, 2010) or grouped
predictors (Chen and Wang, 2009; Li and Li, 2004; Ma, Song and Huang, 2007; Chen, Wang and
Ishwaran, 2010), providing a concise representation of the genomic features affecting patient outcome.
Although useful, the majority of these methods identify a set of covariates common to all patients and
as a result may “distort what is observed” in the presence of population heterogeneity (Aalen, 1988).
Survival-supervised clustering approaches naturally accommodate heterogeneity, providing for efficient
and effective identification of patient subgroups (Dettling and Buhlmann, 2002; Li and Gui, 2004).
However, these approaches do not identify salient features associated with subgroups; and, as with the
aforementioned methods, may sacrifice power and accuracy by focusing on one (or a few) data sets in
isolation.
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2 DAWSON AND KENDZIORSKI
Latent Dirichlet allocation (LDA, Blei, Ng and Jordan (2003)) models are particularly well-tailored
for accommodating heterogeneity, selecting features, and characterizing complex interactions in a high-
dimensional setting. By far the most common application concerns identifying groups of words that
co-occur frequently (topics) across large collections of text (e.g., a collection of abstracts, emails, or
manuscripts). The derived topics provide insight into the collections’ content overall as well as into
the specific content within a document; and estimated document-specific distributions over topics are
useful in classifying new documents (Blei, Ng and Jordan (2003); Porteous et al. (2008); Biro, Szabo
and Benczur (2008)).
A recent extension allows for topic estimation to be supervised by a response that is suitably de-
scribed by a generalized linear model (Blei and McAuliffe, 2008). So-called supervised LDA (sLDA)
debuted with a study of movie reviews (text) and estimated topics (collections of co-occurring words in
a review) that determined the number of stars (supervising response) a movie received. Derived topics
included ones having highest weight on words such as ‘power’, ‘perfect’, ‘fascinating’ and ‘complex’;
another with highest weight on ‘routine’, ‘awful’, ‘featuring’, ‘dry’; a third on ‘unfortunately’, ‘least’,
‘flat’, ‘dull’; and so on. The movie-review-specific distribution over topics proved useful in classifying
movies. Those with highest weight on the ‘power’ topic generally had a high number of stars while
those with highest weight on the ‘unfortunately’ topic had a low number; those with weight on the
‘routine’ topic most often ended up in the middle. Differences between the distributions also provided
insights into differences between movies that received a similar number of stars, as well as insights
into the connotative nature of word choice (e.g., pictures described as ‘films’ rating higher than those
referred to as ‘movies’).
Our interest here is not in evaluating movies. However, it is important to note that the questions
addressed in Blei and McAuliffe (2008) are identical in structure to the most important questions we
face in cancer genomics. In the former, questions include: ‘Given reviews and ratings for a group of
movies, can we identify topics - collections of words that co-occur frequently in some reviews and less
frequently in others ? Can each individual movie be described by a distribution over those topics ?
Can distributions over topics provide insights into differences between similarly rated movies ? And
can a movie-specific distribution over topics be used to predict what the rating of a new movie will
be ?’ In cancer genomics, the questions include: ‘Given genomic, clinical, and survival information on
a group of patients, can we identify topics that are collections of genomic and clinical features that
co-occur frequently in some patients and less frequently in others ? Can a patient be well described
by a distribution over those topics ? Can distributions over topics provide insights into the genomic
differences between two patients with similar survival ? And can a patient-specific distribution over
topics be used to predict survival of an individual patient ?’
To address these types of questions, we extend LDA for use in a clinical and genomic setting. Unlike
in the textual domains of Blei, Ng and Jordan (2003), Porteous et al. (2008) and Biro, Szabo and
Benczur (2008), the definition of a document here is not obvious. Section 2.4 details the construction
of documents, one for each patient, where words describe clinical events, treatment protocols, and
genomic information from multiple sources. As we show in Section 3, application of traditional LDA
to this collection of documents provides for the identification of topics useful in characterizing patient
subpopulations as well as individual patients in a study of ovarian cancer conducted as part of The
Cancer Genome Atlas (TCGA) project (National Cancer Institute and National Human Genome Re-
search Institute, 2011). Survival supervised LDA (survLDA) is developed in Section 2.2 to facilitate
topic supervision by a time-to-event response, which further improves patient-specific characterization
and prediction.
2. Methods.
2.1. The LDA model.. We briefly review the LDA model as detailed in Blei et al. 2003. Assume
there are D documents indexed by i = 1, . . . , D, each of which consists of Ni words. The vocabulary
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is the unique set of length V indexed by v = 1, . . . , V , from which the documents’ words arise, and
is usually taken to be the union of all words over documents. Further assume that there are K latent
‘topics’ indexed by k = 1, . . . ,K, that govern the assignment of words to documents. Each topic
corresponds to a discrete distribution over the V words in the vocabulary, with parameters given by
the V -vector τk. Likewise, each document is assumed to be associated with mixing coefficients θi over
the K topics, indicating its partiality with respect to word sources.
For a given document i, Ni words arise from the following generative process given the system-wide
hyperparameters α (a K-vector Dirichlet parameter) and the τ1:K (the topic V -vectors):
1. Draw topic proportions θi ∼ Dirichlet(α)
2. For each of the Ni words, indexed by j:
(a) Draw a topic assignment Zij |θi ∼Multinomial(1, θi) (Note Zij ∈ {1, . . . ,K})
(b) Draw a word Wij |Zij , τ1:K ∼Multinomial(1, τZij ) (Note Wij ∈ {1, . . . , V })
With this model in place, a variational expectation-maximization (EM) algorithm may be used to
estimate the joint posterior distribution of θi and Zi,1:Ni given wi,1:Ni , α and τ1:K for each document
i (E-step) and then to estimate the system-wide hyperparameters α and τ1:K (M-step). Upon conver-
gence, the variational EM yields optimal values for the key quantities of interest, namely posterior
estimates for θ1:D and τ1:K .
We note that the topics engendered by unsupervised LDA are, well, unsupervised. If there is a
relationship between certain words and an outcome of interest, the model may be hard pressed to find
it as the algorithm does not have access to the outcome. While one may certainly be interested in the
structure of documents and their constituent topics, the focus in our setting is often on relationships
between topics and an outcome of interest. When the outcome can be modeled by a generalized linear
model, supervised LDA sLDA can be used Blei and McAuliffe (2008). Time-to-event outcomes such
as survival, however, do not fall naturally into this class due to the presence of (often abundant)
censoring. We have therefore extended the sLDA framework to time-to-event supervising outcomes, a
framework we will call survLDA, in order to use these kinds of outcomes to inform the estimation of
topic distributions.
2.2. The survival supervised LDA model. Assume the same setup as in Section 2.1 with D docu-
ments indexed by i, a vocabulary of size V , and K topics with corresponding discrete distributions
τ1:K . Additionally, the introduction of supervision through a time-to-event outcome means that, just
as a document’s partiality to certain topics through θi impacts its constituent words, those topics affect
the survival outcome Ti. An indicator variable for death/censoring is also observed for each document
and denoted by δi.
The system-wide model parameters for the survLDA model include a K-vector Dirichlet parameter
α, the topic V -vectors τ1:K , and survival response parameters β (a K-vector of regression coefficients)
and h0(·) (baseline hazard). When they are available for a given document i, Ni words and a survival
response Ti arise from the following generative process:
1. Draw topic proportions θi ∼ Dirichlet(α)
2. For each of the Ni words, indexed by j
(a) Draw a topic assignment Zij |θi ∼Multinomial(1, θi) (Note Zij ∈ {1, . . . ,K})
(b) Draw a word Wij |Zij , τ1:K ∼Multinomial(1, τZij ) (Note Wij ∈ {1, . . . , V })
3. Compute the K-vector Z¯i s.t. Z¯ik = #{Zij = k}/Ni
4. Draw a survival response Ti|Z¯i, β, h0 from the survival function corresponding to a Cox propor-
tional hazards model with hazard function h(t|Z¯i) = h0(t) exp{β′Z¯i}
Note that we are using a Cox proportional hazards model (Cox, 1972), with each regression coefficient
βk exhibiting the beneficent (negative) or deleterious (positive) effect of topic k on survival. The form
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of h0 may be chosen by the user and may be parametric (such as using a Weibull survival model) or
nonparametric.
As in LDA, a variational EM algorithm may be used to estimate the joint posterior distribution
of θi and Zi,1:Ni given wi,1:Ni , Ti, δi, α, τ1:K , β and h0 for each document i (E-step) and then to
estimate the system-wide hyperparameters α, τ1:K , β and h0 (M-step). The derivation of this varia-
tional EM is given in Appendix A. As detailed in Appendix B, we introduce into the variational EM
an ‘uninteresting’ background topic to act as a benchmark with respect to the supervising outcome.
Without loss of generality, say this is the last (Kth) topic. Then the distribution over the vocabulary
for the background topic (τK) may be identified by placing count weights on the known ‘background’
words, a tiny amount of weight on all other words (say, 0.001) and re-normalizing so that the sum over
the entire V -vector is one. Non-background topics are then different deviations from this benchmark
that express themselves through differential survival. In our application, the background topic would
describe ‘featureless’ documents that contain only the ubiquitous adjuvant therapy information, noth-
ing more. Upon convergence, the variational EM yields posterior estimates for the key quantities of
interest: posterior estimates for the θ1:D as well as for the composition (τ1:K) and outcome effect (β)
of the K topics.
2.3. Prediction. Given a new patient with document w1:N and a fitted model {α, τ1:K}, the posterior
mean Z¯new = Z¯|w1:N , α, τ1:K can be obtained in order to estimate from what topics this new patient
draws words, and in what proportions. As was the case during model fitting, this posterior must be
approximated via variational inference. We do so by following the same procedure as outlined in the
first subsection of Appendix A, except that all survival-related terms in the evidence lower bound are
dropped; see the third subsection of Appendix A for details. We note that this approach is analogous to
that in Blei and McAuliffe (2008), where they point out that the prediction protocol does not depend
on the particular response type.
Given Z¯new, measures related to topic membership can be predicted for the new patient. This may be
done qualitatively (e.g., “This patient is predicted to belong strongly to the second topic and survival
for that topic is poor, hence her prognosis is bad.”) or quantitatively (e.g., predicting median survival
time using the parametric survival model; see Appendix A).
2.4. Document construction in the TCGA cohort. In most applications of LDA, the definition of
‘document’ is obvious. That is not the case here. In studies of cancer genomics, data are available
in the form of text (e.g., treatments received, a clinician’s evaluation of response to treatment, etc.);
there are also often disparate non-textual measurements (e.g., binary, count, continuous, factor). By
translating these measurements into words, and thus patients into textual documents, the LDA and
survLDA models may be used for inference.
Our population of interest is the ovarian cancer cohort from The Cancer Genome Atlas (TCGA)
(National Cancer Institute and National Human Genome Research Institute, 2011). For these women,
clinical information such as time of surgery, adjuvant therapies, time of recurrence, treatment at recur-
rence, overall survival, and dozens of other variables are available. Also available are high-throughput
measurements of gene expression, methylation, SNP/CNVs, and microRNAs. For document construc-
tion, we used words associated with adjuvant therapy, expression as assayed by the Affymetrix HT
Human Genome U133A chip, and methylation as assayed using the Illumina Infinium HumanMethy-
lation27 BeadChip. Out of the cohort as accessed in April of 2011, 448 of the women were not missing
more than half of their gene expression or methylation measurements and received at least the standard
therapy of a platinum and taxane. A document was constructed for each of the 448 patients.
For a given patient, a drug-related word was added to her document for every drug given to her during
adjuvant treatment. For example, a patient receiving two platinums and a taxane would have the words
‘platinum’, ‘platinum’ and ‘taxane’ added to her document. Related drugs were collected together (e.g.,
the many varied platinums) and adjuvant drug therapies not given to at least 10% of the women were
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not considered. To help ensure that documents contained words corresponding to meaningful genes, we
considered those genes for which expression or methylation is multi-modal, as assessed by MCLUST
(Fraley and Raftery, 2002, 2006). Specifically, a gene’s expression distribution was deemed multi-modal
if MCLUST preferred a two-component over a one-component model when given only those choices.
Filtering by known genes, non-missingness, and multi-modality reduced the number of gene expression
measurements considered from 14,500 to 7,727. Given the multi-modal genes, a patient’s document
received a gene word, given by the gene name, if that patient showed extreme expression for that
gene. The same word was added again if the patient showed extreme methylation. As most genes have
multiple sites at which methylation was measured, we considered each methylation site in each gene
separately. So a patient’s document receives copies of the word “geneX” if that patient had extreme
expression for geneX (one copy added) as well as multiple hyper (or hypo) methylated sites (one copy
added per hyper- or hypo-methylated site). For both types of data, extreme was defined as being in
the minor mode of the genes’ multi-modal distribution, if the probability of being so, as estimated by
MCLUST, exceeded 95%. As extreme may manifest as high or low expression (or methylation), one
cannot infer direction of the gene expression or methylation measurement from word frequency; i.e.,
high frequency does not necessarily correspond to high expression. This is a consequence of the way in
which documents were constructed and could be changed.
In an effort to improve power to detect survival-related topics, a second filter was applied. Specifically,
we considered the 234 uncensored patients and partitioned them into three groups of 78 based on
survival times. A gene’s word was removed if word frequency did not vary across groups. For gene
expression (methylation), we required a difference of at least 10 (15) words between at least two of the
survival groupings, leaving 201 (1,063) vocabulary words. Note that the censored women still received
words based on gene expression and methylations; they merely did not contribute to the decisions made
during this pre-filtering. A typical document contained approximately 350 words (mean 347; median
= 132), on the order of a PubMed abstract.
3. Application to TCGA data. Given documents constructed as described above for each of
the 448 women considered, we applied LDA as well as survLDA. The outcome of interest is all-cause
mortality and for the survLDA application, we used a Weibull model for the baseline hazard. The
background topic (the seventh topic) was assigned non-trivial weight only on the adjuvant therapy
words platinum and taxane, as this setup would constitute an ‘uninteresting’ document since all pa-
tients received these two treatments (they were inclusion criteria in the TCGA ovarian project). In all
analyses, we use K = 7 topics, the last being the background topic.
3.1. Results. Application of (unsupervised) LDA provides two quantities of primary interest. The
first are the topics τ1:K , or estimated distributions over words; and the second are the document-specific
distributions over topics θ1:D. The left panel of Figure 1 presents the topic-specific distributions over
words for each topic. Red (blue) indicates an overabundance (dearth) of a word’s weight in the corpus
belonging to a particular topic; white indicates an amount equivalent to an even spread over all non-
background topics. The overabundance of some words and paucity of others characterize the topics,
allowing one to differentiate among them. For example, consider topics 5 and 6. The right panel of
Figure 1 shows twenty words having high weight in topic 5 (upper), and twenty with high weight
in topic 6 (lower). It is clear that patients described primarily by these topics differ with respect to
aberrations for this collection of genes. Of interest is determining whether this difference translates to
a difference in overall survival.
The top left panel of Figure 2 shows a heat map of estimated topic membership for the six non-
background topics (rows), clustered over patients (columns). As expected, none of the patients exhibited
more than minimal weight in the background topic (not shown). Patient membership within a topic
ranges from 0 (nil weight in the topic, deep blue) to 1 (wholly belonging to the topic, red). As shown,
most patients have high weight in a single topic, while a few are best described by mixtures over topics.
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Topics 5 and 6 are the largest topics, in the sense that they contain the most weight over the cohort.
The top right panel of Figure 2 shows Kaplan-Meier (KM) curves for each topic shown in the left
panel. The curves are generated by weighting the TCGA patients’ survival information by their topic
membership; hence a patient whose θi had 50% weight in topic one and 50% weight in topic two would
count as ‘half a person’ in the KM estimation of those curves, but would not contribute to the survival
curves associated with other topics. As shown, there is some, albeit limited, separation with respect
to survival over topics. Topics 5 and 6, for example, have rather similar survival (80% vs 70% at two
years), in spite of the genomic differences highlighted in Figure 1. This type of finding is consistent
with recent studies showing remarkable genetic heterogeneity among cancer patients that appear to be
clinically similar (Jones et al., 2008).
The bottom left and right panels of Figure 2 similarly show estimated topic membership and KM
survival curves for the survLDA analysis. While the analysis uses a parametric Weibull survival model,
empirical (weighted) KM curves are presented to facilitate comparison to the (unsupervised) LDA
approach. In survLDA, the largest topics are 1 and 4; and better separation among all topics is
observed. Two topics have poorer than baseline survival (topics 1 and 2), and two have better (topics
5 and 6).
Figure 3 is similar to Figure 1, but shows results from survLDA. For comparison, the word order
shown in Figure 1 is preserved in Figure 3. Topics have also been reordered in Figure 3 to stress
similarity between topics 5 and 6 derived from the LDA analysis and topics 4 and 1 derived from
survLDA. As shown in Figure 3, their topic-specific distributions over words are very similar. This is not
an artifact. Indeed, many of the topics’ high-weight words are consistent between LDA and survLDA.
The consistency as we shift from free-formed topics to survival supervision suggests that there are
subpopulations within the cohort whose constituent topics have strong enough effects on survival that
they are evident even without survival supervision. When survival information is available and used
to supervise topic creation, the subsequent alterations to topics result in a much sharper disparity
in survival rates. Recall that two year survival is about 80% vs. 70% for topics 5 and 6 in the LDA
analysis; that spread increases to 92% vs. 65% under survival supervision for topics 4 and 1 (which
are most similar in structure to topics 5 and 6). We note that this magnitude of differential survival
is on par with results of other ovarian cancer studies (Tothill et al., 2008; The Cancer Genome Atlas
Research Network, 2011).
With respect to words that distinguish between topics 4 and 1, we note that the following words
consistently show high frequency in the poor survival group: NDC80 (a spindle checkpoint regulator
associated with breast cancer (Bieche et al., 2011)) RXRA (a transcriptional regulator associated with
breast cancer (Lawrence et al., 1998; Ditsch et al., 2012)), MANF (a gene coding a highly conserved
protein with unknown function with mutations often observed in lung, breast, prostate (Shridhar
et al., 1996) and pancreatic cancers (Shridhar et al., 1997)), and INTS6 (a tumor suppressor known
to be involved in prostate cancer (Filleur et al., 2009)). Further note that NDC80, RXRA and INTS6
would not likely have been identified in this cohort by another approach, as the marginal p-values
from a Cox proportional hazards test are far from overwhelming (NDC80 p=0.6, 0.98, 0.07; RXRA
p=0.22, 0.37, 0.27; INTS6 p=0.38, 0.8, 0.59; all p-values are for gene expression and then for two
methylations measured in the gene). MANF (p=0.02, 0.46, 0.08) is the only one of these that shows
even a nominally significant marginal effect on survival. Further investigation of these and other genes
that display markedly different abundance patterns between these patient subtypes might elucidate
the mechanisms that underlie differences between the groups. To this end, word cloud representations
such as those shown in Figure 4 may prove useful.
Additionally, the patient-specific distributions over topics are useful in that they characterize the
genomic aberrations underlying individual patients. Figure 5 shows 20 high-weight words from topic 4
and 20 from topic 5 (rows). Fifteen patients are shown (columns): five identified as strongly belonging
to topic four (θi,4 > 0.99, left column), five identified as strongly belonging to topic five (θi,5 > 0.99,
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right column), and five whom the model classifies as a mixture of both (θi,5 > 0.4 and θi,5 > 0.4, middle
column). (Note that topics 4 and 5 were chosen since most patients are described almost exclusively
by a single topic as shown in Figure 2; however, there are some best described by a mixture. In the
survLDA analysis, most of these latter patients are a mixture between topics 4 and 5.)
The differences in genomic aberrations shown among the groups in Figure 5 are clear. Patients
defined primarily by topic 4 have many of the high-weight topic 4 words in their document. The
same is true for topic 5, while those who are a mixture have some realizations from both sets of
words. The right side of the plot shows p-values from Cox proportional hazards tests conducted on the
entire cohort. For each gene, a test was conducted for expression as well as methylation measurements
associated with that gene. The p-value reported is the minimum among those tests. As shown, few of
these genes would be identified as significant using a standard Cox based test since the gene expression
measurements are not significantly associated with survival across the entire cohort, even though they
show clear differences for some subsets of patients.
To evaluate the utility of survLDA for patient-specific prediction, we split the TCGA cohort into a
training and test set (75% and 25% of the cohort, respectively). The full barcoding, document creation
and survLDA model fitting procedures were applied to the training set. Documents for the test set
women were derived using the abnormality indications for the genes and methylations surviving filtering
that arose from the training set document creation. These documents in hand, the survLDA output
was used to predict topic membership for the test set, using the prediction approach given in Section
2.3.
There were 23 women in the test set with more than 80% weight in topic 1. The patient-specific
distributions over topics for the other women in the test set were not concentrated on a different topic,
but had weight rather evenly spread out across topics 2-6. The pink (red) line in Figure 6 shows the
Kaplan-Meier curve for the test (training) set women predicted as having more than 80% weight in
topic 1, while the light blue line is the survival curve for test set women predicted as having less than
20% weight in topic 1. As shown in Figure 6, survival of women largely described by topic 1 in the
training and test sets is similar, while survival for those test cases predicted as not being well described
by topic 1 is considerably different, indicating some predictive power for patients strongly described
by a single topic. Simulations (not shown) indicate that topic specificity as well as prediction improves
with either more or larger documents; and work toward these ends is ongoing.
4. Discussion. A problem pervasive in genomic based studies of disease concerns taking large,
diverse data sets collected on a cohort of patients and using the information contained therein to
characterize patient subtypes as well as individuals. Computational scientists often address this problem
by performing analysis within a single data type and comparing results subsequently in an effort to
identify a signal supported by the disparate analyses (e.g., a gene’s SNPs, expression, and methylation
all associate with a phenotype). Comparing results manually has its obvious disadvantages. At the
same time, meta-analysis approaches such as Fisher’s combined probability test can be limited by
low power (Zaykin et al., 2002); and efforts to combine data directly are challenged by measurements
on different scales with differential dependencies. The LDA based framework proposed here addresses
these challenges by transforming the information contained in high-throughput genomic screens into
text. Doing so has both advantages and disadvantages.
One advantage is that data integration is seamless. In the implementation presented, a word for a
gene is assigned to a patient’s document if the gene shows extreme expression; the same word is assigned
if the gene shows extreme methylation. In this way, a document may contain copies of words associated
with extreme genomic features, measured from expression and/or methylation. The number of copies
is proportional to the number of measurements for which the gene is extreme: a gene with extreme
expression and methylation will have more copies of that word than a gene showing extreme expression
alone. Although we have demonstrated the approach using expression and methylation measurements
(and treatment information), applications that use additional types of data are easily incorporated
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into the framework.
A second advantage is that the threshold required for a gene to be included in the analysis is much
lower than would be required with other methods. As detailed in Section 2.4, some pre-selection of
genes is done, but the selection does not require even nominally significant association with a survival
end-point, as is often required in survival studies with high-dimensional covariates (Li and Luan, 2003;
Chen and Wang, 2009; Liu et al., 2009). As shown in Figure 5, this allows for the identification of many
important genes, some previously known to be involved in cancer, that would not otherwise have been
considered.
Application of LDA to patient documents reveals groups of genomic aberrations that co-occur to-
gether (topics) and then characterizes individual patients by those groups. The topics themselves are
useful in that they define collections of genes, methylations or other covariates among which undiscov-
ered interactions might occur, while the patient-specific distributions over topics give insights into the
similarities and differences among patients that go beyond the information that can be gained from
grouping by like outcome. In our application to the TCGA ovarian project, there was some consistency
between the topics derived under unsupervised and supervised analyses, suggesting that the approach
may produce topics whose constituents have similar survival profiles even in settings where survival
information is not available. Of course, when survival is available, survLDA may be used to improve
inference.
Our analysis of the TCGA ovarian cohort identified several genes whose products and methylations
bear further interrogation, some already known to be involved in cancer. Our investigations of the
predictive ability of the approach are mixed. While there is some ability for prediction, improvements
are expected with increases in the number of patients as well as improvements in document creation
strategies. For instance, in the testing set we could evaluate predictive inference in one group, the only
one for which the test women had strong indications of topic membership or exclusion. Simulations
(not shown) suggest that this limitation is largely due to the relatively small sample size in the test
set and the minimal amount of word replication in our documents. More work is required to ascertain
the power associated with sample size, document size, word frequencies, and replication, which in turn
requires further experimentation with the method of document construction.
As this framework relies heavily on the words contained in a patient’s document, much work is
required to develop and evaluate methods of document construction. Our approach to assign a word
for any gene showing extreme expression or methylation was motivated by Zilliox and Irizarry (2007),
where the authors identify bi-modal genes and, for each individual and each gene, assign a binary
variable indicative of mode membership. The resulting gene expression ‘barcode’ for each patient
proved extremely useful in classifying patients into biologically meaningful groups in Zilliox and Irizarry
(2007); and, as demonstrated, the extrapolation of their approach proved to be an effective strategy
here. At the same time, one could imagine assigning a word associated with a pathway if any gene in
that pathway was extreme as assessed by expression, methylation, SNP profile, etc. This would increase
the frequency with which words appeared; and our preliminary evaluation suggests that this can be
useful, but can also result in topics that are not clearly distinct with respect to high-weight words.
Another possibility is to assign an increasing number of words in direct proportion with signal. For
example, consider breaking a gene’s expression into deciles, say, and assign one to ten words for each
document (e.g., a value between the sixth and seventh deciles gets seven words). We did not favor this
approach for two main reasons. First, the approach assumes linearity of expression and methylation
which is often not the case. Second, the approach results in documents having few unique words,
which reduces specificity of topics as well as document specific distributions over topics. Document
construction continues to be explored, and improvements are expected to prove useful in a number of
settings.
In addition to the means by which covariates are translated into words, there are many aspects of the
proposed methods that require further development. In particular, survLDA assumes the simplest of
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Dirichlet priors on the distributions of topics over patients and therefore the documents are considered
conditionally independent given α. While this is a reasonable assumption for the TCGA data set we
considered, there are other realms where correlation among the documents could arise. For example,
one could have multiple documents arising from the same subject, one for each time point or tissue; or,
when integrating multiple cancer types, subjects with the same type of cancer would be expected to be
more alike than subjects with differing cancer types. Adding such hierarchy has already been explored
for traditional LDA (Teh et al., 2006), presenting a starting point for methodological extension.
Similarly, the composition of the topics themselves is essentially free. Were it not for our imposition
of a background topic, the topics would be completely unstructured a priori. As it is, K − 1 topics are
still governed solely by the data. This need not be the case, as methods similar to those proposed for
construction of a background topic (see Appendix B) could be extended. In particular, the Dirichlet
prior could be modified directly, or a set of restrictions could be imposed for each topic and groups of
words so that certain words cannot appear together, or may only appear together in certain topics. Some
of these modifications were considered in Andrzejewski and Zhu (2009), providing another starting
point for future extension.
In summary, it is becoming increasingly clear that studies aimed at solving the most challenging
problems in cancer genomics involve highly diverse types of data collected on large groups of patients.
Many methods will prove useful. We suspect that advantage will be gained from methods that are able
to integrate data and account for cohort heterogeneity, allow supervision by outcomes of interest such
as survival, provide for patient specific inference, and facilitate prediction of unobserved outcomes.
The proposed approach provides tools for these purposes in an effort to help ensure that maximal
information is obtained from powerful genomic based studies of disease.
APPENDIX A: THE SURVLDA VARIATIONAL EM
Posterior inference. For a given document i with survival response dyad (Ti, δi), the key quantity
of interest is
p(θi, Zi,1:Ni |wi,1:Ni , Ti, δi, α, τ1:K , β, h0) =
p(θi|α)
(∏Nj
j=1 p(Zij |θi)p(Wij |Zij , τ1:K)
)
p(Ti, δi|Zi,1:Ni , β, h0)∫
p(θi|α)
∑
Zi,1:Ni
(∏Ni
j=1 p(Zij |θi)p(Wij |Zij , τ1:K)
)
p(Ti, δi|Zi,1:Ni , β, h0) dθ
(A.1)
where the normalizing value is known as the evidence. As in LDA (Blei, Ng and Jordan, 2003) and
sLDA (Blei and McAuliffe, 2008), the evidence cannot be exactly computed efficiently, so we will use
mean-field variational inference using Jensen’s inequality to approximate it. For reviews of this and
other variational methods, see Wainwright and Jordan (2008) and Jordan et al. (1999).
Let pi = {α, τ1:K , β, h0} and qi(θi, Zi,1:Ni) denote a variational distribution of the latent variables.
For computational tractability, we choose a fully factorized variational distribution:
qi(θi, Zi,1:Ni |γi, φ1,1:Ni) = qi(θi|γi)
Ni∏
j=1
qi(Zij |φij)(A.2)
where
θi|γi ∼ Dir(γi) and Zij |φij ∼ Discrete(φij).
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With this quantity defined, the lower bound for the evidence given by Jensen’s inequality is
log p(Wi,1:Ni , Ti, δi|pi) = log
∫
θi
∑
Zi,1:Ni
p(θi, Zi,1:Ni ,Wi,1:Ni , Ti, δi|pi) dθ
= log
∫
θi
∑
Zi,1:Ni
p(θi, Zi,1:Ni ,Wi,1:Ni , Ti, δi|pi)
q(θi, Zi,1:Ni)
q(θi, Zi,1:Ni)
dθ
= log Eqi
[
p(θi, Zi,1:Ni ,Wi,1:Ni , Ti, δi|pi)
1
q(θi, Zi,1:Ni)
]
≥ Eqi
[
log p(θi, Zi,1:Ni ,Wi,1:Ni , Ti, δi|pi)
1
q(θi, Zi,1:Ni)
]
= Eqi [log p(θi, Zi,1:Ni ,Wi,1:Ni , Ti, δi|pi)] +−Eqi [log q(θi, Zi,1:Ni)](A.3)
where the second term in the lower bound is the entropy H(qi) of the variational distribution. We will
use L(·) to refer to the so-called evidence lower bound (ELBO) given in (A.3). We can expand the
ELBO:
L(Wi,1:Ni , Ti, δi|pi) = Eqi [log p(θi|α)] +
Ni∑
j=1
Eqi [log p(Zij |θi)] +
Ni∑
j=1
Eqi [log p(Wij |Zij , τ1:K)]
+Eqi [log p(Ti, δi|Zi,1:Ni , β, h0)] +H(qi)(A.4)
Thus, an approximation of the posterior given in (A.1) is obtained by maximizing L with respect to
γi and φi,1:Ni . The first, second and third terms in (A.4), as well as the entropy H(qi), are identical
to the corresponding terms in the ELBO for LDA (Blei, Ng and Jordan, 2003) and sLDA (Blei and
McAuliffe, 2008):
Eqi [log p(θi|α)] = log Γ
(
K∑
k=1
αk
)
−
K∑
k=1
log Γ(αk)
+
K∑
k=1
(αk − 1)
Ψ(αk)−Ψ
 K∑
g=1
αg
(A.5)
Ni∑
j=1
Eqi [log p(Zij |θi)] =
Ni∑
j=1
K∑
k=1
φijk
Ψ(αk)−Ψ
 K∑
g=1
αg
(A.6)
Ni∑
j=1
Eqi [log p(Wij |Zij , τ1:K)] =
Ni∑
j=1
K∑
k=1
V∑
v=1
φijkWijv log τkv(A.7)
H(qi) = −
{
log Γ
(
K∑
k=1
γik
)
−
K∑
k=1
log Γ(γik)
+
K∑
k=1
(γik − 1)
Ψ(γik)−Ψ
 K∑
g=1
γig

+
Ni∑
j=1
K∑
k=1
φijk log φijk
}
(A.8)
where Ψ denotes the digamma function. All that remains is to derive the fourth term of (A.4):
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Eq[log p(Ti, δi|Zi,1:Ni , β, h0)] = Eq
[
log
{[
h0(Ti) exp
(
β′Z¯i
)]δi × exp [−H0(Ti) exp (β′Z¯i)]}]
= Eq
[
δi log h0(Ti) + δi β
′Z¯i −H0(Ti) exp
(
β′Z¯i
)]
= δi log h0(Ti) + δiEq
[
β′Z¯i
]−H0(Ti)Eq [exp (β′Z¯i)]
= δi log h0(Ti) + δi β
′φ¯i −H0(Ti)
 Ni∏
j=1
(
exp(
β
Ni
)′φij
)(A.9)
where the K-vector
φ¯i = (1/Ni)
∑Ni
j=1 φij
We use block coordinate-ascent variational inference, maximizing (A.4) with respect to γi and then
each φij in turn. As in sLDA (Blei and McAuliffe, 2008), the terms of (A.4) involving γi are unchanged
from LDA and hence the update for γi is
γnewi = α+
Ni∑
j=1
φij(A.10)
The update for a given φij , however, must be derived anew. We first define the following quantities:
ψi =
Ψ(γi1)−Ψ
 K∑
g=1
γig
 , . . . ,Ψ(γiK)−Ψ
 K∑
g=1
γig

ξij =
[
V∑
v=1
I(Wij = v) log τ1v, . . . ,
V∑
v=1
I(Wij = v) log τKv
]
and then take the partial derivative of (A.4) with respect to φijk:
∂L
∂φijk
= 0 + ψik + ξijk + [− log φijk − 1]
+ δi
βk
Ni
−H0(Ti)
∏
m 6=j
exp
(
β
Ni
)′
φim
 exp(βk
Ni
)
(A.11)
Setting this equal to zero and plugging in φnewijk yields:
φnewijk ∝ exp
ψik + ξijk + δi βk
Ni
−H0(Ti)
∏
m6=j
exp
(
β
Ni
)′
φim
 exp(βk
Ni
)(A.12)
where proportionality means that the components of φnewij are evaluated according to (A.12) and
then normalized so that their sum is one. Variational inference proceeds by iteratively updating the
variational parameters {γi, φi,1:Ni} according to (A.10) and (A.12) in order to find a local optimum for
the ELBO, which in turn best approximates the evidence given in (A.1).
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Parameter estimation. We use maximum likelihood estimation based on variational expectation-
maximization. Our data are D = {Wi,1:Ni , Ti, δi}.
(A.13) L(α, τ1:K , β, h0;D) =
D∑
i=1
{Eqi [log p(θi, Zi,1:Ni ,Wi,1:Ni , Ti, δi)] +H(qi)}
In the expectation step (E-step), we use the variational inference algorithm outlined in the first sub-
section of Appendix A to estimate the approximate posterior distribution for each document-response
pair. In the maximization step (M-step), we maximize the corpus-level ELBO with respect to pi, sub-
ject to some constraints. First, we take α to be (α0/K, . . . , α0/K) where α0 is specified a priori. This
is not necessary; further structure could be placed on α, ranging from a simple Dirichlet prior as in
Blei, Ng and Jordan (2003) to more complicated structures allowing dependence among the documents
more complex than simple conditional independence as in Teh et al. (2006). However we, like Blei and
McAuliffe 2008, prefer letting α be user-defined, which is simple and straightforward, yet allows some
flexibility in the model specification.
The τ1:K updates are unchanged from unsupervised LDA (Blei, Ng and Jordan, 2003; Blei and
McAuliffe, 2008) and are thus calculated in this manner:
(A.14) τˆnewkv ∝
D∑
i=1
Ni∑
j=1
I(Wij = v)φijk
where proportionality means that each τˆnewk is normalized to sum to one.
The regression coefficients that comprise β and the baseline hazard h0 must be numerically optimized
w.r.t. maximizing the portion of the joint ELBO that depends on them. Numerical optimization is
required as no closed form can be derived in general for the maximizing choice of β. The specific
computations this process entails depend on the choice for h0. For example, when an exponential
survival model is chosen, so that h0 = λ, β and λ are numerically optimized by finding the solutions:
(βˆnew, λnew) = argmax L(β, λ)
= argmax
D∑
i=1
δi log λ+ δi β′φ¯i − λTi × Ni∏
j=1
exp
(
β
Ni
)′
φij
(A.15)
Numerical optimization for a Weibull survival model is similar. In contrast, if we use a non-parametric
Breslow estimate (Breslow, 1974) for h0, we first update β given the current value for h0:
(A.16) βˆnew = argmax L(β) = argmax
D∑
i=1
δi log h0 + δi β′φ¯i −H0(Ti) Ni∏
j=1
exp
(
β
Ni
)′
φij

Then, given the updated β = βˆnew, the maximum likelihood estimate of the baseline hazard h0 at
the rth ordered survival time tr is given by Breslow (1974):
(A.17) hˆnew0 (tr|β) =
mr
(tr − tr−1)
∑
j∈Rr exp
(
β′φ¯j
)
where mr is the number of failures at time tr and Rr is the set of patients that have not failed or
been censored by time tr. Regardless, once h0 has been updated an estimate of the cumulative baseline
hazard H0 follows immediately.
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Prediction for a new document. Given a new patient with document w1:N and a fitted model
{α, τ1:K}, the posterior mean Z¯new = Z¯|w1:N , α, τ1:K can be obtained in order to estimate from what
topics this new patient draws words, and in what proportions. This is similar to the procedure outlined
in the Posterior Inference subsection, except that all survival-related terms in the ELBO are dropped.
Thus, under the same variational distribution as given in (A.2), the coordinate ascent updates are
γnew = α+
N∑
j=1
φj(A.18)
φnewjk ∝ exp (ψik + ξjk)(A.19)
where again j indexes words, k indexes topics and proportionality means that the components of φnewj
are evaluated according to the above update and then normalized so that their sum is one. Note that
this variational sequence is identical to that in Blei and McAuliffe (2008), as they point out that it
does not depend on the particular response type.
Given Z¯new, measures related to topic membership can be predicted for a new document. This may
be done qualitatively or quantitatively using the chosen survival model. For example, the predicted
median lifetime can be obtained by solving the following equation for t̂med:
(A.20) exp
[
−H0
(
t̂med
)
exp
(
β′Z¯new
)]
=
1
2
where H0 and β are taken from the fitted survLDA model.
APPENDIX B: IMPOSING A BACKGROUND TOPIC
As mentioned in the text, the documents we are working on are of our own creation and hence
we know their nature. In particular, we know that each patient in the TCGA ovarian cohort received
platinum and taxane as treatment with each of these following surgery was an inclusion criteria.
Consequently an uninteresting background document would include platinum and taxane and nothing
else. The distribution on the background topic may thus be found by placing those weights on those
words and re-normalizing so that their sum is one. In order to avoid negative infinities on the log scale,
a small weight such as a thousandth of a word may be given to each of the words that do not appear
in this background document.
With respect to the variational EM algorithm, imposition of a background topic into LDA may be
achieved by specifying one (say the Kth) topic as the background. In the variational EM, inference in
the E-step proceeds as usual but the M-step is modified so that τK is not updated like the other τ1:(K−1)
but is instead fixed according to the distribution designated by the user. Modification of survLDA so
that it accepts a background topic is similar except that, in addition to the fixation just outlined, βK is
set to 0. In this way the background topic also becomes the topic corresponding to the baseline hazard,
and the βk values of the other topics will reflect increased or decreased force of mortality relative to
that baseline.
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Fig 1: A heat map of the word distributions for the topics derived from LDA, with two insets marked
by black boxes. The background (seventh) topic is not shown. Words are clustered along the rows,
topics are clustered across the columns. The colors range from blue (word under-represented in the
topic) to red (word over-represented in the topic), with white in the middle (average representation).
The insets are close-up views of the boxed regions, which contain the twenty highest-weight words for
topics five (upper right heatmap) and six (lower right heatmap).
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Fig 2: Top left: A heat map of estimates of θ (patient-specific distributions over topics) for each patient
derived from LDA (upper left) and survLDA (lower left). Topics are given across the rows and patients
are clustered across the columns. Colors range from deep blue (0) to red (1). The right panels show
Kaplan-Meier curves for the LDA (upper) and survLDA (lower) topics. The background (seventh)
topic is not shown. Topic k’s curve is generated using all 448 documents, weighted by the θik.
18 DAWSON AND KENDZIORSKI
Fig 3: A heat map of the word distributions for the topics derived from survLDA, with two insets
marked by black boxes. The background (seventh) topic is not shown. The rows are in the same order
as in Figure 2, topics are clustered across the columns. The colors range from blue (word under-
represented in the topic) to red (word over-represented in the topic), with white in the middle (average
representation). The insets are close-up views of the boxed regions, which contain the twenty highest-
weight words for topics 5 and 6. Note the similarities between topics 4 and 1 derived from survLDA
and topics 5 and 6 derived from LDA.
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Fig 4: Word clouds generated using the twenty highest-weight words for topics 1 (left) and 4 (right)
derived from survLDA.
20 DAWSON AND KENDZIORSKI
TMC5
TBC1D13
SYT13
SLC27A6
SEPT10
RUSC2
RIBC2
RASAL1
PML
PIPOX
P2RY1
NXF3
METRN
LTC4S
LMF1
LIME1
KCNK15
HEYL
CLEC11A
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TPPP3
TKTL1
TAGLN
SPINK5
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CNGA3
ALOX12
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− log10(p)
Fig 5: The rows show the twenty highest-weight words from the fourth and fifth topics derived from
survLDA. The columns show words (presence in black and absence in white) for fifteen patients: 5
identified as strongly belonging to topic 4 (θi,4 > 0.99, left column), 5 identified as strongly belonging
to topic 5 (θi,5 > 0.99, right column), and 5 for whom the model indicates a mixture of the two
(θi,5 > 0.4 and θi,5 > 0.4, middle column). The bars on the right indicate the marginal p-values for
each gene, which is taken to be the minimum of all p-values from Cox proportional hazard-based score
tests among all expression and methylation measurements associated with that gene. Note that only
three of the genes shown would have survived a pre-filtering step using a nominal 0.01 level.
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Fig 6: Kaplan Meier curves for selected topic structures within the training and testing data. The red
(pink) line represents the 99 training set (23 testing set) women whose documents are identified as
having more than 80% weight in topic 1; the light blue line is the survival curve for the 26 test set
women predicted as having less than 20% weight in topic 1.
